Calcium channel blockade and renal function

Area of Science:

• Nephrology
• Pharmacology
• Cardiovascular Medicine

Background:

• Calcium channel blockers (CCBs) are used to treat hypertension.
• Their effects on renal function are a significant clinical consideration.
• Existing research primarily focuses on acute effects, with limited data on long-term renal impacts.

Purpose of the Study:

• To review the renal effects of calcium channel blocking agents.
• To investigate their influence on renal hemodynamics and electrolyte excretion.
• To examine effects on renin release and pharmacokinetics in renal impairment.

Main Methods:

• Review of animal and human studies on CCBs and renal function.
• Analysis of acute and long-term clinical data.
• Examination of pharmacokinetic studies in patients with renal disease.

Main Results:

• Animal and acute human studies show CCBs increase renal blood flow, glomerular filtration rate, urine flow, and electrolyte excretion.
• Long-term clinical data on renal effects are lacking.
• Acute studies show increased renin release; long-term studies show no change in plasma renin levels.
• Verapamil pharmacokinetics are altered in uremic patients (smaller volume of distribution, decreased clearances).
• Nifedipine pharmacokinetics remain similar in uremic and normal subjects.

Conclusions:

• CCBs demonstrate beneficial acute renal effects.
• Further long-term studies are needed to fully understand their renal impact.
• Pharmacokinetic profiles of CCBs differ in patients with renal impairment, necessitating individualized treatment approaches.